311 Hospitals
- Gold Level - Grand Hospital Award (IHF, 2022): Highest IHF recognition for excellence in healthcare quality, patient experience, clinical outcomes, cost efficiency, and workforce wellbeing.
- Honourable Award - Excellence in Quality & Patient Safety (IHF, 2022): Recognised for implementing an integrated, holistic quality management and patient safety model in Egypt.
- Bronze Level - Healthcare Workers’ Wellbeing Award (AHA, 2023): Awarded for a national strategy to enhance healthcare worker morale and engagement in collaboration with Egypt’s Ministry of Health.
- Accreditation
Please Enquire
- Healthcare Asia: Employee Engagement of the Year (2019)
- Paediatric Service Provider of the Year in Asia-Pacific (2021)
- Obstetrics and Gynaecology Service Provider of the Year in Asia-Pacific (2024)
- Women and Children Specialist Provider of the Year in Asia-Pacific (2024)
- Advanced Paediatric Service Provider of the Year in Asia-Pacific (2024)
- Gold Class 1 Award for excellence and organisational performance.
The Oncology Speciality at Marengo Asia Hospitals, Gurugram, India offers comprehensive, patient-focused care for the prevention, diagnosis, and treatment of a wide range of cancers. The department follows internationally aligned, evidence-based oncology protocols tailored to each patient’s cancer type, stage, treatment goals, and overall health status.
Services include cancer screening and diagnosis, medical, surgical, and radiation oncology, chemotherapy and targeted therapies, immunotherapy, and supportive and palliative care. Patients benefit from coordinated care delivered by experienced oncologists, surgeons, radiologists, pathologists, and specialised oncology nursing teams working collaboratively to ensure accurate diagnosis, patient safety, and optimal treatment outcomes.
Supported by advanced diagnostic imaging, modern treatment facilities, and comprehensive monitoring systems, Marengo Asia Hospitals is recognised for its clinical excellence, high safety standards, and commitment to compassionate, long-term cancer care.
- Accreditation
- Best Critical Care Hospital (2024-25) - Recognised by Mid-Day for excellence in critical care services and patient outcomes.
- World’s Best Specialised Hospitals 2025 - Listed by Newsweek among the world’s leading specialised hospitals, highlighting clinical excellence and advanced care.
- Certificate of Recognition for Excellence in Healthcare Services (2023) - Awarded by Times Healthcare Leaders in recognition of outstanding healthcare delivery and quality standards.
- Accreditation
- National Recognition in Transplant Medicine: GoBroad-affiliated haematology institutions, including Shanghai ZhaXin and LiQuan centres, have been ranked among China’s Top 30 hematopoietic stem cell transplant centres for three consecutive years, reflecting sustained excellence in complex transplant care.
- International Professional Acceptance: In 2025, GoBroad haematology programs were formally admitted to the European Society for Blood and Marrow Transplantation (EBMT), underscoring compliance with internationally recognised clinical and research standards.
- Prestigious Scientific & Technological Awards: Senior physicians and research teams associated with GoBroad have received multiple high-level national honours for advancements in haematology and oncology, including:
- Second Prize, Scientific and Technological Progress Award from the Ministry of Education of China and the Chinese Medical Association for pioneering work in allogeneic HSCT for refractory malignant hematologic diseases.
- Chinese Medical Science and Technology Award for contributions to clinical innovation.
- Chinese Pharmaceutical Association Science and Technology Innovation Award recognising translational research impact.
- Beijing Science and Technology Award for advancements in medical science and patient outcomes.
- Chinese Anti-Cancer Association Science and Technology Award for leadership in oncology research.
- Leadership in Advanced Therapies: Beijing GoBroad Hospital is widely recognised as a leading centre for CAR-T cell therapy, integrating clinical care with cutting-edge research and innovation.
Please Enquire
- Accreditation
- Excellence Award for Green Healthcare Facilities – Golden Level
- Accreditation
- Accreditation
- Accreditation
Please Enquire
- Joint Commission International (JCI) Accreditation
- HIMSS Digital Health Recognition
- ISO Certifications for Quality Standards
- Recognition for Excellence in Pediatric Oncology Care
- International Research and Academic Collaborations
- Multiple Healthcare and Patient Safety Awards
- Accreditation
Damansara Specialist Hospital 2 (DSH2), Kuala Lumpur
Kuala Lumpur, Malaysia
Number of Beds: 132
Ask your healthcare adviser for the best multiple options and choose the one that meets your expectations
Request for an Expert Opinion
Get Insight with our Blogs
7 Reasons African Patients Trust India for Advanced Leukemia Treatment
Leukemia is one of the most difficult types of blood cancer because it currently involves the bone marrow and blood-forming tissues. Receiving a timely diagnosis and advanced treatment is an important factor in improving survival and quality of life.
.png)